Related Experiment Video
Updated: May 18, 2026

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
Deprivation and ethnicity impact on diabetes control and use of treatment regimen
R J Thompson1, K Agostini, L Potts
1Children and Young People's Diabetes Service, University College London Hospitals, London, UK.
Insights
Deprivation and ethnicity significantly impact pediatric diabetes care, affecting insulin therapy choices and glycemic control (HbA1c). Equitable care requires better consideration of diverse ethnic group needs.
Area of Science:
- Pediatric Endocrinology
- Health Disparities
- Diabetes Management
Background:
- Socioeconomic status and ethnicity can influence healthcare access and outcomes.
- Understanding these factors is crucial for equitable management of chronic conditions like Type 1 diabetes in children.
Purpose of the Study:
- To investigate the influence of deprivation and ethnicity on diabetes care delivery in a pediatric clinic.
- To assess how these factors affect insulin treatment regimens, glycemic control (HbA1c), and service satisfaction.
Main Methods:
- A cohort of 325 children and young people with Type 1 diabetes were analyzed.
- Data included insulin treatment type (twice-daily, multiple daily injections, continuous subcutaneous insulin infusion), HbA1c levels, clinic attendance rates, deprivation indices, and ethnicity.
- Statistical analyses were performed to correlate these variables.
Main Results:
- Insulin pump therapy (continuous subcutaneous insulin infusion) was associated with lower HbA1c levels.
- White British and Asian Indian ethnic groups were more likely to receive insulin pump therapy.
- Deprivation was linked to ethnicity and HbA1c, though clinic attendance was not affected by deprivation.
Conclusions:
- Deprivation and ethnicity play a significant role in diabetes control and the utilization of intensive insulin therapy in pediatric patients.
- There is a need for improved consideration of the specific needs of different ethnic groups to ensure equitable diabetes care delivery.
Aims:
Deprivation and/or ethnicity impact on care delivery. We have assessed how these factors influence diabetes care in a paediatric clinic.
Methods:
We related access to care [type of insulin treatment regimen-twice daily, multiple daily injections and insulin pump therapy (continuous subcutaneous insulin infusion)], measures of care process (HbA(1c)) and an approximate measure of satisfaction with the service (clinic attendance rate) in 325 (170 male) children and young people with Type 1 diabetes (mean age 10.6 years, mean duration of diabetes of 4.5 years), with indices of deprivation and ethnicity.
Results:
Of the 325 children and young people, 2.7% received twice-daily insulin, 48.4% multiple daily injections and 48.9% continuous subcutaneous insulin infusion. Median clinic HbA(1c) was 62 mmol/mol (7.8%) and those receiving the insulin pump therapy had the lowest HbA(1c). Four ethnic groups were represented; White British 81.6%, Asian non-Indian 6.5%, African 8.1% and Asian Indian 3.8%. Mean deprivation score was 21.06. White British and Asian Indian groups were more likely to receive insulin pump therapy (χ(2) = 50.3; P < 0.001). Attendance rates were 94.1% and did not differ across ethnic groups. Deprivation was related to ethnicity and HbA(1c) (R(2) = 0.02; P = 0.02). There was no relationship between clinic attendance and deprivation. Insulin regimen and ethnicity were associated with HbA(1c) (R(2) = 0.096; P < 0.001). Similar findings were obtained when analysis was confined to the White British population.
Conclusions:
These data suggest that deprivation and ethnicity influence diabetes control and how intensive insulin therapy is utilized. A better consideration of the needs of different ethnic groups is required to ensure equitable care delivery in paediatric diabetes.
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Diabetic Retinopathy
Diabetic Nephropathy
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Type II Diabetes II: Pathophysiology